The integrated approach is designed to adapt to the evolving needs of new therapeutic modalities, delivering both speed and performance.

Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...

Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

After President Donald Trump warned recently about Iranian "sleeper cells" potentially operating in North America, Canadian opposition lawmakers are accusing their government of allowing operatives ...